SAESCO GROUP

SAESCO’s vision is to become a EUROPEAN LEADER IN THE DISTRIBUTION OF DISRUPTIVE HEALTH TECHNOLOGIES in the fields of MINIMALLY INVASIVE SURGERY, GYNECOLOGY, UROLOGY, ENDOSCOPY, AND SEGMENTS OF CARDIAC CARE AND INTERVENTIONAL CARDIOLOGY.

History of SAESCO

SAESCO Medical was founded in Barcelona in 2009, focusing on the growing space of Obesity and Metabolic related Medical Devices.

The founding team, with over 20 years of clinical experience, identified the opportunity for less invasive, endoluminal approaches to the treatment of obesity.

Since its inception, the company’s goal has been to identify, select and bring the best medical technologies to market, fostering their adoption and growth by providing superior customer service and training for physicians, from the laboratory to the OR.

The company developed a cutting-edge portfolio and, simultaneously, established high service levels based on proximity and training in the latest and most advanced medical techniques in the following fields:

Bariatric Surgery and Endoscopy for Obesity and Metabolic Diseases
Therapeutic and Conventional Endoscopy
Vascular Surgery, Gynecology and Urology

2010 to 2018 was a period of growth and clinical innovation for SAESCO Medical. During this time:

SAESCO Medical enabled the first POSE® obesity surgery procedures outside the US and expanded endobariatric innovation across Europe.
SAESCO Medical introduced 6-month intragastric balloons at European scale.
SAESCO Medical enabled the first TIF® procedures in the United Kingdom.
Through continued growth and innovative products, SAESCO Medical became a leader in the Spanish endobariatric market.

Definitions:

POSE®: Primary Obesity Surgery Endoluminal
TIF®: Transoral Incisionless Fundoplication

In 2019, SAESCO GROUP began expanding into other regions of Europe and made its first investment in a company:

Medispar: a Belgian distributor of medical devices for Obesity Surgery, Minimally Invasive Surgery, Therapeutic and Bariatric Endoscopy and Gynecology.This integration marked the beginning of SAESCO GROUP’s European expansion strategy focused on investments in growing, profitable, companies that fit well in the group and benefit from the resources and scale of the company.

In 2021 and 2022, SAESCO GROUP continued its inorganic growth and European expansion with additional investments:

Pelvitec: A leading Dutch distributor of urology medical devices.
HMS Endo: A Polish distributor of Urology and Minimally Invasive Surgery products, as well as devices for Therapeutic and Bariatric Endoscopy.
Medical Dynamics: A leading Dutch distributor of products for Gynecology and Obstetrics, Minimally Invasive Surgery, and Urology.

In 2023, SAESCO GROUP continued organic growth initiatives and set up two new centralized logistics centers, one in Utrecht, Netherlands and another in Vilassar de Mar, Barcelona, Spain.

In 2024, SAESCO GROUP welcomed two additional companies to the group while continuing to develop cross-selling opportunities across the product portfolio throughout its growing sales network while centralizing back-office financial and administrative functions.

Fixaplus: Spanish distributor of medical devices mainly focused on Colorectal Surgery and Laparoscopy.
Dimed: Leading Italian distributor of Urology and Gynecology products that opened the Italian market to the SAESCO GROUP.

In 2025, SAESCO GROUP took a giant step forward with the integration of two additional companies, doubling the size of the Group. This operation was facilitated by a strategic investment by Miura Partners, a leading Spanish private equity firm.

Cardiolink: Large Spanish distributor of medical devices specialized in General Surgery, Urology, Gynecology, Proctology, Cardiac Surgery, and Interventional Cardiology.
Rivolution: A fast-growing German distributor of Minimally Invasive Surgery products with a strong focus on endoscopic staplers. This acquisition marked an important entry point into the large Germany domestic market and the broader DACH market.

With the investment from Miura Partners, SAESCO GROUP strengthened its financial and operational capabilities to continue its rapid growth strategy in key clinical areas.

So far in 2026 SAESCO GROUP has continued with strong internal growth, as well as the strategic integrations of companies in Italy and Spain.

Medcomp: A niche Italian distributor specialized in Gynecology surgical products, reinforcing SAESCO GROUP’s presence in these clinical sectors.
Sangüesa: Storied Spanish distributor of surgical consumables and innovative products for Neurosurgery, Trauma and Gynecology.